Related Experiment Video
Updated: Feb 18, 2026

Synthesis of Core-shell Lanthanide-doped Upconversion Nanocrystals for Cellular Applications
Published on: November 10, 2017
Preparation and evaluation of wet-milled usnic acid nanocrystal suspension for better bioaffinity
Changhai Qu1, Lingling Zhang2, Xueying Du1
1a Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica , Beijing University of Chinese Medicine , Beijing , PR China.
Objective:
To prepare a new nanosystem of usnic acid (UA) with higher solid content and higher bioavailability.
Methods:
Usnic acid nanocrystal suspensions were prepared by the wet milling method, and then the particle size distributions and zeta potential were determined with the Nano ZS90 laser diffraction particle size analyzer. The particles morphology of UA-NCS were observed by scanning electron microscopy method. In addition, solubility and dissolution of UA-NCS in water and phosphate buffer solution were determined in vitro, analyzed by the HPLC method, and then the cellular uptake and pharmacokinetic were carried out on the Caco-2 cells and rats, analyzed by the UPLC-MS/MS method.
Results:
Particle size distributions and zeta potential of the UA nanocrystal suspension were 268.7 ± 4.0 nm and -23.1 ± 0.7 mV, respectively. About the dissolution rate of UA, nanosuspension were significantly faster and higher than common suspension in water and phosphate buffer. And in cellular uptake experiments, the ratio of the maximum amount of drug in unit protein of UA nanosuspension to common suspension was 2.8 times. In rats, oral absorption of nanocrystal UA were superior to the ordinary groups, with the 348% of the maximum concentration and 181% of the AUC after the same dosage administration.
Conclusion:
The wet-milling technique was suitable for the preparation of UA nanocrystal suspension, and a new nanosystem of UA with higher solid content and higher bioavailability was achieved.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Drug Solubility Enhancement

